Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1
1(50.0%)
N/A
1(50.0%)
2Total
Phase 1(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03116750Completed

Post-Market Clinical Follow-up Study with ASPIREX®S to Assess the Safety and Effectiveness in the Treatment of DVT

Role: lead

NCT05071872Completed

PMCF of Rotarex®S & Aspirex®S Catheters in Treating Thrombotic Occlusion of Arteriovenous Graft

Role: lead

NCT04010123Completed

Post-Market Clinical Follow Up of Rotarex®S Catheter

Role: lead

NCT04092972Not ApplicableUnknown

Safety and Efficacy of Atherectomy on VasculaR Functions

Role: collaborator

NCT00314002Phase 1Terminated

Catheter Thrombectomy in Patients With Massive Pulmonary Embolism

Role: lead

All 5 trials loaded